tiprankstipranks
Trending News
More News >
Definitive Healthcare Corp (DH)
NASDAQ:DH
US Market

Definitive Healthcare Corp (DH) Stock Forecast & Price Target

Compare
69 Followers
See the Price Targets and Ratings of:

DH Analyst Ratings

Hold
8Ratings
Hold
2 Buy
5 Hold
1 Sell
Based on 8 analysts giving stock ratings to
Definitive
Healthcare Corp
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DH Stock 12 Month Forecast

Average Price Target

$4.20
▲(4.22%Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Definitive Healthcare Corp in the last 3 months. The average price target is $4.20 with a high forecast of $5.00 and a low forecast of $3.00. The average price target represents a 4.22% change from the last price of $4.03.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","3":"$3","5":"$5","7":"$7","9":"$9"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3,5,7,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.75,2.923076923076923,3.0961538461538463,3.269230769230769,3.4423076923076925,3.6153846153846154,3.7884615384615383,3.9615384615384617,4.134615384615385,4.3076923076923075,4.480769230769231,4.653846153846153,4.826923076923077,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.75,2.8615384615384616,2.973076923076923,3.0846153846153848,3.1961538461538463,3.307692307692308,3.4192307692307695,3.5307692307692307,3.6423076923076927,3.753846153846154,3.865384615384616,3.976923076923077,4.088461538461539,{"y":4.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.75,2.769230769230769,2.7884615384615383,2.8076923076923075,2.826923076923077,2.8461538461538463,2.8653846153846154,2.8846153846153846,2.9038461538461537,2.923076923076923,2.9423076923076925,2.9615384615384617,2.980769230769231,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.59,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.97,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.97,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.37,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.69,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.74,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.11,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.86,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.23,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.64,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.75,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5.00Average Price Target$4.20Lowest Price Target$3.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DH
TipRanks AITipRanks
Not Ranked
TipRanks
$4
Hold
-0.74%
Downside
Reiterated
06/07/25
Definitive Healthcare Corp's overall stock score reflects a combination of moderate financial performance and positive short-term technical indicators. Financial challenges, especially in profitability and equity trends, weigh heavily on the score. On the positive side, technical analysis suggests upward momentum, and the recent earnings call indicates operational improvements and strategic progress, despite ongoing sector-specific challenges.
Barclays Analyst forecast on DH
Saket KaliaBarclays
Barclays
$3
Sell
-25.56%
Downside
Reiterated
05/09/25
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF), Natera (NASDAQ: NTRA) and Definitive Healthcare Corp (NASDAQ: DH)
Stifel Nicolaus Analyst forecast on DH
David GrossmanStifel Nicolaus
Stifel Nicolaus
$6$5
Buy
24.07%
Upside
Reiterated
05/09/25
Stifel Nicolaus Remains a Buy on Definitive Healthcare Corp (DH)
Needham
Hold
Reiterated
05/09/25
Cautious Hold Rating for Definitive Healthcare Corp Amid Promising Developments and Retention Concerns
Morgan Stanley Analyst forecast on DH
Craig HettenbachMorgan Stanley
Morgan Stanley
$5
Hold
24.07%
Upside
Reiterated
05/09/25
Definitive Healthcare Corp: Hold Rating Amid Positive Developments and Market Challenges
Canaccord Genuity Analyst forecast on DH
David HynesCanaccord Genuity
Canaccord Genuity
$5
Hold
24.07%
Upside
Reiterated
05/09/25
Definitive Healthcare Corp: Stabilization Amidst Challenges Warrants Hold Rating
William Blair Analyst forecast on DH
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH) and Silence Therapeutics (NASDAQ: SLN)
BTIG
Hold
Downgraded
05/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)
Robert W. Baird Analyst forecast on DH
Joseph VruwinkRobert W. Baird
Robert W. Baird
$5$3
Hold
-25.56%
Downside
Reiterated
04/08/25
Definitive Healthcare Corp (DH) PT Lowered to $3 at BairdBaird analyst Joe Vruwink lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $5.00) while maintaining a Neutral rating.
Goldman Sachs Analyst forecast on DH
Kash RanganGoldman Sachs
Goldman Sachs
$4.5$3
Hold
-25.56%
Downside
Reiterated
03/04/25
Definitive Healthcare Corp (DH) PT Lowered to $3 at Goldman SachsGoldman Sachs analyst Kash Rangan lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $4.50) while maintaining a Neutral rating.
Stephens
$5
Hold
24.07%
Upside
Initiated
12/19/24
Definitive Healthcare initiated with an Equal Weight at StephensDefinitive Healthcare initiated with an Equal Weight at Stephens
Deutsche Bank  Analyst forecast on DH
George HillDeutsche Bank
Deutsche Bank
$7$5
Hold
24.07%
Upside
Reiterated
08/08/24
Definitive Healthcare price target lowered to $5 from $7 at Deutsche BankDefinitive Healthcare price target lowered to $5 from $7 at Deutsche Bank
Bank of America Securities Analyst forecast on DH
Allen LutzBank of America Securities
Bank of America Securities
Buy
Reiterated
07/31/24
Bank of America Securities Keeps Their Buy Rating on Definitive Healthcare Corp (DH)
J.P. Morgan Analyst forecast on DH
Anne SamuelJ.P. Morgan
J.P. Morgan
$7$5
Sell
24.07%
Upside
Downgraded
07/31/24
Definitive Healthcare downgraded to Underweight from Neutral at JPMorganDefinitive Healthcare downgraded to Underweight from Neutral at JPMorgan
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DH
TipRanks AITipRanks
Not Ranked
TipRanks
$4
Hold
-0.74%
Downside
Reiterated
06/07/25
Definitive Healthcare Corp's overall stock score reflects a combination of moderate financial performance and positive short-term technical indicators. Financial challenges, especially in profitability and equity trends, weigh heavily on the score. On the positive side, technical analysis suggests upward momentum, and the recent earnings call indicates operational improvements and strategic progress, despite ongoing sector-specific challenges.
Barclays Analyst forecast on DH
Saket KaliaBarclays
Barclays
$3
Sell
-25.56%
Downside
Reiterated
05/09/25
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF), Natera (NASDAQ: NTRA) and Definitive Healthcare Corp (NASDAQ: DH)
Stifel Nicolaus Analyst forecast on DH
David GrossmanStifel Nicolaus
Stifel Nicolaus
$6$5
Buy
24.07%
Upside
Reiterated
05/09/25
Stifel Nicolaus Remains a Buy on Definitive Healthcare Corp (DH)
Needham
Hold
Reiterated
05/09/25
Cautious Hold Rating for Definitive Healthcare Corp Amid Promising Developments and Retention Concerns
Morgan Stanley Analyst forecast on DH
Craig HettenbachMorgan Stanley
Morgan Stanley
$5
Hold
24.07%
Upside
Reiterated
05/09/25
Definitive Healthcare Corp: Hold Rating Amid Positive Developments and Market Challenges
Canaccord Genuity Analyst forecast on DH
David HynesCanaccord Genuity
Canaccord Genuity
$5
Hold
24.07%
Upside
Reiterated
05/09/25
Definitive Healthcare Corp: Stabilization Amidst Challenges Warrants Hold Rating
William Blair Analyst forecast on DH
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH) and Silence Therapeutics (NASDAQ: SLN)
BTIG
Hold
Downgraded
05/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)
Robert W. Baird Analyst forecast on DH
Joseph VruwinkRobert W. Baird
Robert W. Baird
$5$3
Hold
-25.56%
Downside
Reiterated
04/08/25
Definitive Healthcare Corp (DH) PT Lowered to $3 at BairdBaird analyst Joe Vruwink lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $5.00) while maintaining a Neutral rating.
Goldman Sachs Analyst forecast on DH
Kash RanganGoldman Sachs
Goldman Sachs
$4.5$3
Hold
-25.56%
Downside
Reiterated
03/04/25
Definitive Healthcare Corp (DH) PT Lowered to $3 at Goldman SachsGoldman Sachs analyst Kash Rangan lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $4.50) while maintaining a Neutral rating.
Stephens
$5
Hold
24.07%
Upside
Initiated
12/19/24
Definitive Healthcare initiated with an Equal Weight at StephensDefinitive Healthcare initiated with an Equal Weight at Stephens
Deutsche Bank  Analyst forecast on DH
George HillDeutsche Bank
Deutsche Bank
$7$5
Hold
24.07%
Upside
Reiterated
08/08/24
Definitive Healthcare price target lowered to $5 from $7 at Deutsche BankDefinitive Healthcare price target lowered to $5 from $7 at Deutsche Bank
Bank of America Securities Analyst forecast on DH
Allen LutzBank of America Securities
Bank of America Securities
Buy
Reiterated
07/31/24
Bank of America Securities Keeps Their Buy Rating on Definitive Healthcare Corp (DH)
J.P. Morgan Analyst forecast on DH
Anne SamuelJ.P. Morgan
J.P. Morgan
$7$5
Sell
24.07%
Upside
Downgraded
07/31/24
Definitive Healthcare downgraded to Underweight from Neutral at JPMorganDefinitive Healthcare downgraded to Underweight from Neutral at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Definitive Healthcare Corp

1 Month
xxx
Success Rate
8/14 ratings generated profit
57%
Average Return
+2.08%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +2.08% per trade.
3 Months
xxx
Success Rate
7/14 ratings generated profit
50%
Average Return
-10.52%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -10.52% per trade.
1 Year
David GrossmanStifel Nicolaus
Success Rate
4/14 ratings generated profit
29%
Average Return
-28.12%
reiterated a buy rating 2 months ago
Copying David Grossman's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -28.12% per trade.
2 Years
xxx
Success Rate
4/14 ratings generated profit
29%
Average Return
-35.01%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -35.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DH Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
2
2
2
0
Buy
1
1
1
1
2
Hold
6
5
5
5
6
Sell
1
1
2
1
2
Strong Sell
0
0
0
0
0
total
8
9
10
9
10
In the current month, DH has received 2 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. DH average Analyst price target in the past 3 months is 4.20.
Each month's total comprises the sum of three months' worth of ratings.

DH Financial Forecast

DH Earnings Forecast

Next quarter’s earnings estimate for DH is $0.05 with a range of $0.05 to $0.05. The previous quarter’s EPS was $0.05. DH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.11% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.
Next quarter’s earnings estimate for DH is $0.05 with a range of $0.05 to $0.05. The previous quarter’s EPS was $0.05. DH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.11% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.

DH Sales Forecast

Next quarter’s sales forecast for DH is $59.24M with a range of $58.64M to $59.55M. The previous quarter’s sales results were $59.19M. DH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.
Next quarter’s sales forecast for DH is $59.24M with a range of $58.64M to $59.55M. The previous quarter’s sales results were $59.19M. DH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.

DH Stock Forecast FAQ

What is DH’s average 12-month price target, according to analysts?
Based on analyst ratings, Definitive Healthcare Corp’s 12-month average price target is 4.20.
    What is DH’s upside potential, based on the analysts’ average price target?
    Definitive Healthcare Corp has 4.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DH a Buy, Sell or Hold?
          Definitive Healthcare Corp has a consensus rating of Hold which is based on 2 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Definitive Healthcare Corp’s price target?
            The average price target for Definitive Healthcare Corp is 4.20. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $5.00 ,the lowest forecast is $3.00. The average price target represents 4.22% Increase from the current price of $4.03.
              What do analysts say about Definitive Healthcare Corp?
              Definitive Healthcare Corp’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of DH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis